Safety and Immunogenicity of Fluzone Quadrivalent Vaccine Administered to Healthy Children 6 to < 36 Months of Age

  • Fling, John (PI)

Project Details

StatusFinished
Effective start/end date5/08/16 → 4/08/21

Funding

  • Sanofi Pasteur, Inc.: $112,325.00

Keywords

  • Biotechnology & Drug Development, Immunology